Background
5.8
million Americans are living with Alzheimer’s disease, over 16 million Americans actively support their care.
2002
was the year the last therapy approved for modestly addressing Alzheimer’s disease was developed. There are no disease-modifying therapies available to treat Alzheimer’s.
1 in 3
seniors die with Alzheimer’s or dementia. It kills more than breast cancer and prostate cancer combined.
Every 65 seconds
another person develops Alzheimer’s disease; by 2050, someone in the United States will develop the disease every 33 seconds.
$290 billion
was the estimated cost of treating Alzheimer’s in the United States in 2019. Unabated by the introduction of effective disease deferring or disease modifying therapies, 14 million Americans will suffer from the disease and the cost of Alzheimer’s care will rise to $1.1 trillion in 2050, more than the current national defense budget.
(Source: Alzheimer’s Association Facts and Figures 2019)